← Open Payments lookup

MICHAEL TRAN: Open Payments

NPI 1952513830 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$618 in 34 payments from 10 companies in 2025. Trend: 2023 $540 · 2024 $610 · 2025 $618

Food & beverage: $618
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.10$185
ABBVIE INC.9$168
Neurocrine BioSciences, Inc.4$69
Otsuka America Pharmaceutical, Inc.3$56
Janssen Pharmaceuticals, Inc3$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Axsome Therapeutics, Inc.1$22
Noven Therapeutics, LLC1$16
Teva Pharmaceuticals USA, Inc.1$14
Vanda Pharmaceuticals Inc.1$14

Products named: COBENFY, VRAYLAR, INGREZZA, REXULTI, INVEGA SUSTENNA, CAPLYTA, Auvelity, SPRAVATO.

Industry payments across SC — which companies pay providers there.